Robert J. Kelley - 07 Apr 2023 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Chief Executive Officer, Director
Signature
/s/ Gillian Green, Attorney-in-fact for Robert J. Kelley
Issuer symbol
TLIS
Transactions as of
07 Apr 2023
Transactions value $
$0
Form type
4
Filing time
11 Apr 2023, 16:06:18 UTC
Previous filing
02 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock option (right to buy) Award $0 +500K $0.00 500K 07 Apr 2023 Common Stock 500K $0.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date of March 1, 2023 and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.